These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33871158)
1. Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine. Wu X; Farooq MA; Li T; Geng T; Kutoka PT; Wang B J Biomed Mater Res A; 2021 Nov; 109(11):2111-2119. PubMed ID: 33871158 [TBL] [Abstract][Full Text] [Related]
2. Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery. Amin MK; Boateng JS Ther Deliv; 2019 Aug; 10(8):493-514. PubMed ID: 31496377 [No Abstract] [Full Text] [Related]
4. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613 [TBL] [Abstract][Full Text] [Related]
5. Preparation of alginate coated chitosan microparticles for vaccine delivery. Li X; Kong X; Shi S; Zheng X; Guo G; Wei Y; Qian Z BMC Biotechnol; 2008 Nov; 8():89. PubMed ID: 19019229 [TBL] [Abstract][Full Text] [Related]
6. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier. Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436 [TBL] [Abstract][Full Text] [Related]
7. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Pawar D; Mangal S; Goswami R; Jaganathan KS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265 [TBL] [Abstract][Full Text] [Related]
8. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties. Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849 [TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response. Pawar D; Jaganathan KS Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier. Li Q; Wang W; Hu G; Cui X; Sun D; Jin Z; Zhao K Molecules; 2021 Apr; 26(9):. PubMed ID: 33923304 [TBL] [Abstract][Full Text] [Related]
12. Characteristics, Cryoprotection Evaluation and In Vitro Release of BSA-Loaded Chitosan Nanoparticles. Yan Q; Weng J; Wu X; Wang W; Yang Q; Guo F; Wu D; Song Y; Chen F; Yang G Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32549252 [TBL] [Abstract][Full Text] [Related]
13. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system. Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103 [TBL] [Abstract][Full Text] [Related]
14. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum. Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187 [TBL] [Abstract][Full Text] [Related]
15. Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery. Li XY; Li X; Kong XY; Shi S; Guo G; Zhang J; Luo F; Zhao X; Wei YQ; Qian ZY; Yang L J Nanosci Nanotechnol; 2010 Aug; 10(8):4850-8. PubMed ID: 21125819 [TBL] [Abstract][Full Text] [Related]
16. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E. Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System. Ghahfarokhi MR; Dini G; Movahedi B Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762 [TBL] [Abstract][Full Text] [Related]
18. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762 [TBL] [Abstract][Full Text] [Related]
19. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
20. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery. Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]